<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: November 30, 2000
[ ] TRANSITION REPORT PURSUANT TO SECTION 13(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to________
COMMISSION FILE NUMBER: 0-31667
MFC DEVELOPMENT CORP.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
DELAWARE 13-3579974
(State or other jurisdiction of incorporation (I.R.S.Employer Identification No.)
or organization)
271 NORTH AVENUE, NEW ROCHELLE, NY 10801
(Address of principal executive offices) (Zip Code)
</TABLE>
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (914) 636-3432
N/A
(Former name, former address and former fiscal year, if changed since last
report)
__________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes (x) No( )
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS
Indicate by checkmark whether the registrant has filed all documents and reports
required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act
of 1934 subsequent to the distribution of securities under a plan confirmed by a
court. Yes ( ) No ( )
APPLICABLE ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding
of each of the issuer's classes of common stock, at January 12, 2001: 1,800,000.
<PAGE> 2
MFC DEVELOPMENT CORP.
(A SUBSIDIARY OF FRMO CORP.)
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2000
<TABLE>
<CAPTION>
Page No.
PART I
<S> <C>
Item 1. Financial Statements .................................... 2
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations .............................. 17
Item 3. Quantitative and Qualitative Disclosures About
Market Risk ...................................................... 22
PART II
Item 6. Exhibits and reports on form 8-K ........................ 23
</TABLE>
1
<PAGE> 3
MFC Development Corp. and Subsidiaries
(A SUBSIDIARY OF FRMO CORP.)
Index to Consolidated Financial Statements
PART I
ITEM 1. FINANCIAL STATEMENTS
<TABLE>
<S> <C>
Consolidated Balance Sheets -- November 30, 2000 (unaudited) and February 29, 2000 .............. 3
Consolidated Statements of Operations (unaudited) --
Nine months and three months November 30, 2000 and 1999 ...................................... 5
Consolidated Statement of Stockholders' Equity (unaudited) -- Nine months ended
November 30, 2000 ............................................................................ 6
Consolidated Statements of Cash Flows (unaudited) -- Nine months ended November
30, 2000 and 1999 ............................................................................ 7
Notes to Consolidated Financial Statements (unaudited) .......................................... 8
</TABLE>
2
<PAGE> 4
MFC Development Corp.and Subsidiaries
(A SUBSIDIARY OF FRMO CORP.)
Consolidated Balance Sheets
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
(UNAUDITED)
<S> <C> <C>
ASSETS
Current assets:
Cash & cash equivalents $ 580,233 $ 581,408
Mortgage and notes receivable - current 28,448 26,597
Finance receivables, net 4,345,860 2,479,999
Other current assets 97,379 103,994
---------- ----------
Total current assets 5,051,920 3,191,998
---------- ----------
Property and equipment:
Property and equipment, at cost 537,428 348,575
Less accumulated depreciation and amortization 180,872 115,794
---------- ----------
356,556 232,781
---------- ----------
Other assets:
Real estate held for development and sale 498,548 510,880
Mortgage and notes receivable 3,131,110 3,152,683
Accrued interest receivable - related party mortgage 321,150 321,150
Loans receivable 136,609 98,381
Other 61,544 95,991
Net assets of discontinued operations - 1,174,892
---------- ----------
Total other assets 4,148,961 5,353,977
---------- ----------
Total assets $9,557,437 $8,778,756
========== ==========
</TABLE>
See notes to interim consolidated financial statements.
3
<PAGE> 5
MFC Development Corp. and Subsidiaries
(A SUBSIDIARY OF FRMO CORP.)
Consolidated Balance Sheets (continued)
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
(UNAUDITED)
<S> <C> <C>
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses $ 308,022 $ 213,683
Current portion of notes payable 58,254 19,282
Due to finance customers 2,104,345 1,402,546
Income taxes payable 11,360 5,367
Other current liabilities 34,258 20,000
---------- ----------
Total current liabilities 2,516,239 1,660,878
---------- ----------
Other liabilities:
Notes payable, including $306,500
payable to related party at November 30, 2000 378,299 24,655
Deferred income 2,407,311 2,407,311
---------- ----------
Total other liabilities 2,785,610 2,431,966
---------- ----------
Minority interest in subsidiary 105,612 -
---------- ----------
Commitments and contingencies
Stockholders' equity:
Preferred stock - $.001 par value;
Authorized - 2,000,000 shares;
Issued and outstanding -0- shares - -
Common stock - $.001 par value;
Authorized - 40,000,000 shares;
Issued and outstanding - 1,800,000 shares at
November 30, 2000 and 1,816,462 shares at February 29, 2000 1,800 1,816
Capital in excess of par value 5,968,420 5,996,739
Accumulated deficit (1,820,244) (1,312,643)
---------- ----------
Total stockholders' equity 4,149,976 4,685,912
---------- ----------
Total liabilities and stockholders' equity $9,557,437 $8,778,756
========== ==========
</TABLE>
See notes to interim consolidated financial statements.
4
<PAGE> 6
MFC Development Corp. and Subsidiaries
(A SUBSIDIARY OF FRMO CORP.)
Consolidated Statements of Operations
(unaudited)
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
NOVEMBER 30, NOVEMBER 30,
2000 1999 2000 1999
---- ---- ---- ----
<S> <C> <C> <C> <C>
REVENUES
Sale of real estate $ -- $ 85,000 $ 69,000 $ 296,000
Rental income 23,409 33,154 70,229 85,339
Interest from mortgages 22,832 58,062 68,942 174,592
Income from the purchase
and collections of medical receivables 301,735 197,932 745,114 807,513
Medical management service fees 239,879 -- 659,829 --
----------- ----------- ----------- -----------
Total income 587,855 374,148 1,613,114 1,363,444
----------- ----------- ----------- -----------
COSTS AND EXPENSES
Real estate 77,505 153,857 305,718 518,292
Medical receivables 323,485 357,586 1,063,211 988,402
Medical management services 228,078 -- 739,013 --
Corporate expenses 127,382 146,716 331,409 335,660
Depreciation and amortization 22,176 15,774 65,076 44,029
----------- ----------- ----------- -----------
Total costs and expenses 778,626 673,933 2,504,427 1,886,383
----------- ----------- ----------- -----------
Loss from operations (190,771) (299,785) (891,313) (522,939)
----------- ----------- ----------- -----------
Other income (expense):
Interest income 8,173 4,933 19,858 7,327
Interest expense (5,558) (6,183) (19,432) (37,895)
Minority interest in net income of subsidiary (612) -- (612) --
----------- ----------- ----------- -----------
2,003 (1,250) (186) (30,568)
----------- ----------- ----------- -----------
Loss from continuing operations before
provision for income taxes (188,768) (301,035) (891,499) (553,507)
Provision for income taxes 4,928 4,925 15,130 15,223
----------- ----------- ----------- -----------
Loss from continuing operations (193,696) (305,960) (906,629) (568,730)
Income from discontinued operations, net of taxes
(including gain on sale of subsidiary of $-0- for the
three months ended November 30, 2000 and 1999,
$381,182 and $96,303 for the nine months ended
November 30, 2000 and 1999, respectively) -- 60,920 399,028 353,443
----------- ----------- ----------- -----------
Net Loss $ (193,696) $ (245,040) $ (507,601) $ (215,287)
=========== =========== =========== ===========
Basic and diluted loss per common share:
Loss from continuing operations $ (0.11) $ (0.17) $ (0.50) $ (0.31)
Income from discontinued operations -- 0.03 0.22 0.19
----------- ----------- ----------- -----------
Basic and diluted loss per common share $ (0.11) $ (0.14) $ (0.28) $ (0.12)
=========== =========== =========== ===========
Number of shares used in computation of basic and
diluted earnings per share 1,800,000 1,816,462 1,809,638 1,816,462
=========== =========== =========== ===========
</TABLE>
See notes to interim consolidated financial statements.
5
<PAGE> 7
MFC Development Corp.and Subsidiaries
(A SUBSIDIARY OF FRMO CORP.)
Consolidated Statement of Stockholders' Equity
February 29, 2000 through November 30, 2000
(unaudited)
<TABLE>
<CAPTION>
ADDITIONAL TOTAL
COMMON STOCK PAID-IN (ACCUMULATED STOCKHOLDERS' COMPREHENSIVE
SHARES AMOUNT CAPITAL DEFICIT) EQUITY (LOSS) INCOME
------ ------ ------- -------- ------ ------------
<S> <C> <C> <C> <C> <C> <C>
BALANCE, FEBRUARY 29, 2000 1,816,462 $ 1,816 $ 5,996,739 $(1,312,643) $ 4,685,912
PURCHASE AND RETIREMENT OF
TREASURY STOCK (16,462) (16) (28,319) -- (28,335)
NET LOSS -- -- -- (507,601) (507,601) $ (507,601)
-----------
COMPREHENSIVE LOSS $ (507,601)
--------- ----------- ----------- ----------- ----------- ===========
BALANCE, NOVEMBER 30, 2000 1,800,000 $ 1,800 $ 5,968,420 $(1,820,244) $ 4,149,976
========= =========== =========== =========== ===========
</TABLE>
See notes to interim consolidated financial statements.
6
<PAGE> 8
MFC Development Corp. and Subsidiaries
(A SUBSIDIARY OF FRMO CORP.)
Consolidated Statements of Cash Flows
(Unaudited)
<TABLE>
<CAPTION>
NINE MONTHS ENDED NOVEMBER 30,
2000 1999
---- ----
<S> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $ (507,601) $ (215,287)
Adjustments to reconcile net loss to net
cash used in operating activities:
Depreciation and amortization 65,076 44,029
Gain on sale of real estate held for development and sale (15,727) (7,903)
Gain on sale of subsidiaries (381,182) (96,303)
Provision for bad debts 207,590 21,994
Minority interest in net income of subsidiary 612 --
Changes in operating assets and liabilities:
Collections from the sale of real estate held for
development and sale, net of payment to participant 69,000 280,634
Additions to real estate held for development and sale (40,941) --
Prepaid expenses, miscellaneous receivables and other assets 41,062 (107,554)
Net assets of discontinued operations (18,926) (74,335)
Accounts payable, accrued expenses and taxes 100,332 (68,824)
Other current liabilities 14,258 (45,139)
----------- -----------
Net cash used in operating activities (466,447) (268,688)
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures & intangible assets (71,161) (85,068)
Finance receivables (2,073,451) 418,598
Due to finance customers 701,799 45,294
Principal payments on notes receivable 19,722 18,032
Loan receivable (79,685) --
Principal payments on loan receivable 41,456 --
Proceeds from sale of subsidiaries 1,575,000 975,000
----------- -----------
Net cash provided by investing activities 113,680 1,371,856
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds of notes payable 726,500 96,779
Principal payments on notes payable (451,573) (950,938)
Sale of equity by affiliate 105,000
Purchase and retirement of treasury stock (28,335) --
----------- -----------
Net cash provided by (used in) financing activities 351,592 (854,159)
----------- -----------
Net (decrease) increase in cash and cash equivalents $ (1,175) $ 249,009
Cash and cash equivalents, beginning of period 581,408 243,012
----------- -----------
Cash and cash equivalents, end of period $ 580,233 $ 492,021
=========== ===========
ADDITIONAL CASH FLOW INFORMATION
Interest paid $ 22,192 $ 41,498
=========== ===========
Income taxes paid $ 17,916 $ 11,701
=========== ===========
NONCASH INVESTING AND FINANCING ACTIVITIES
Assets acquired under capital leases $ 117,689 $ -
=========== ===========
</TABLE>
See notes to interim consolidated financial statements.
7
<PAGE> 9
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared
in accordance with accounting principles generally accepted in the United States
for interim financial information in response to the requirements of Article 10
of Regulation S-X. Accordingly they do not include all of the information and
footnotes required by accounting principles generally accepted in the United
States for complete financial statements. In the opinion of management, the
accompanying unaudited consolidated financial statements contain all adjustments
(consisting only of normal recurring items) necessary to present fairly the
financial position as of November 30, 2000; results of operations for the nine
months and three months ended November 30, 2000 and 1999; cash flows for the
nine months ended November 30, 2000 and 1999; and changes in stockholders'
equity for the nine months ended November 30, 2000. For further information,
refer to the Company's financial statements and notes thereto included in the
Company's Form 10, Amendment No. 2 for the six months ended August 31, 2000 and
for the year ended February 29, 2000. The consolidated balance sheet at February
29, 2000 was derived from the audited financial statements as of that date.
Results of operations for interim periods are not necessarily indicative of
annual results of operations.
Certain prior year amounts were reclassified to conform with the current year
presentation.
2. ORGANIZATION OF THE COMPANY
The consolidated financial statements consist of MFC Development Corp. (the
"Company" or "MFC") and its wholly-owned subsidiaries. MFC is a wholly-owned
subsidiary of FRMO Corp. ("FRM"), whose name was changed on November 29, 2000
from FRM Nexus, Inc. All of FRM's assets and liabilities were transferred to MFC
on August 31, 2000, except for $10,000. Because such entities are under common
control, this transaction has been accounted for in a manner similar to a
pooling of interests on MFC's books.
The consolidated financial statements of MFC include Medical Financial Corp.,
PSI Capital Corp. and its 80% owned subsidiary FRM NY Capital, LLC (formed on
September 14, 2000), Yolo Capital Corp. and its subsidiary Highlands Pollution
Control Corp., Yolo Equities Corp., Nexus Garden City LLC, FRM Court Street LLC,
Nexus Borough Park LLC, Wendcello Corp. ("Wendcello"), and Wendclark Corp.
("Wendclark"). Wendclark was sold May 14, 1999 and Wendcello was sold on June
20, 2000.
The Company was incorporated on May 18, 1990 under the laws of the State of
Delaware as PSI Food Services, Inc. On August 9, 2000, the Company amended its
certificate of incorporation as follows:
8
<PAGE> 10
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. ORGANIZATION OF THE COMPANY (CONTINUED)
1. The Company changed its name from PSI Food Services, Inc. to MFC
Development Corp.
2. The Company increased authorized capital stock from 2,000,000 shares common
stock, par value $.10 per share to 2,000,000 shares preferred stock, par
value $.001 per share and 40,000,000 shares common stock, par value $.001
per share. Stockholders' equity for prior periods was restated to reflect
this change.
In August 2000, the Company purchased and retired 16,462 shares of treasury
stock for $26,689.
On August 31, 2000, FRM filed Form 8-K with the Securities and Exchange
Commission, which disclosed that FRM contemplates on or about November 30, 2000,
or such later date as the registration of the common stock of MFC Development
Corp. shall have become effective, distributing to its shareholders on the
record date one share of MFC common stock for each one share of FRM's
outstanding common stock at the close of business on November 1, 2000 (the
record date). There are presently 1,800,000 shares of common stock of FRM
outstanding. On October 19, 2000 FRM filed Form 8-K with the Securities and
Exchange Commission, which disclosed the board of directors' approval of the
distribution. MFC filed Form 10 on October 2, 2000 to register its common stock.
Amendment Nos. 1 and 2 to Form 10 were filed on November 20, 2000, and December
6, 2000. The Company is currently waiting for any further comment from the
Securities and Exchange Commission.
3. BUSINESS ACTIVITIES OF THE COMPANY
In addition to the two operating divisions of the Company, real estate and
medical, a new division, Capco was formed during the quarter ended November 30,
2000. Operation of the Capco division commenced on September 14, 2000, when the
Articles of Organization in New York State for FRM N.Y. Capital LLC, an 80%
majority owned subsidiary of PSI Capital Corp., a wholly owned subsidiary of the
Company, were filed. This LLC was formed for the purpose of being approved as a
"certified capital company" pursuant to Sections 11 and 1511 of the New York
State Tax Law (herein a "Capco") under the Capco Program Three. A "certified
capital company" as used in this context is a "for profit" entity, such as a
limited liability company, located and qualified to conduct business in New York
State which is certified by the New York State Insurance Department
("Department") based on standards set forth in the New York Tax Law (the
"Statute"). The Capco was approved on November 28, 2000 and certified to
participate in New York's Capco Program Three. The Statute creates a tax credit
incentive mechanism to increase investment of financial resources of insurance
companies into providing venture capital to businesses approved by the
Department as qualified to provide jobs and promote the growth of the economy in
New York State ("Qualified Businesses").
9
<PAGE> 11
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
4. FINANCE RECEIVABLES, NET
Net finance receivables consist of the following:
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
<S> <C> <C>
Gross finance receivables $5,213,989 $2,958,825
Allowance for credit losses (420,078) (212,488)
Deferred finance income (448,051) (266,338)
---------- ----------
$4,345,860 $2,479,999
========== ==========
</TABLE>
These receivables are collateral for a line of credit (see note 6).
The Company purchases the receivables and has the right to return the "invalid
receivables". By contractual definition, these are receivables that have not
been recovered from insurance companies because of denials, requests for
additional information not readily available, or a matter under investigation
within 180 days of the purchase date. For receivables purchased in the years
ended February 29, 2000 and February 28, 1999 and the three months ended May
31, 2000 (unaudited), the Company returned approximately 21%, 17% and 19%,
respectively. The Company does not expect the trend of returned receivables to
change in the future.
In addition to the right to return the invalid receivables to the Seller, the
Company has the right to offset any of its obligations to the Seller by any
invalid receivables. As a result of the right of return and right of offset
features, the Company believes that a valuation allowance generally is not
required for these receivables.
5. PROPERTY AND EQUIPMENT
Property and equipment consists of the following:
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
<S> <C> <C>
Leasehold improvements $ 52,902 $ 51,402
Computer equipment 222,993 173,414
Medical equipment 46,350 32,500
Equipment under capital leases 185,060 67,371
Other equipment and furniture 30,123 23,888
-------- --------
537,428 348,575
Less accumulated depreciation and amortization 180,872 115,794
-------- --------
Property and equipment, net $356,556 $232,781
======== ========
</TABLE>
As of November 30, 2000 and February 29, 2000, accumulated amortization of
equipment under capital leases was $40,617 and $21,699.
Depreciation expense for the nine months ended November 30, 2000 and 1999, which
includes amortization under capital leases was $65,076 and $44,029.
10
<PAGE> 12
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
6. NOTES PAYABLE
Notes payable include the following:
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
<S> <C> <C>
Related party credit line $306,500 $ -
Related party escrow loan - -
Capital lease obligations 130,053 43,937
-------- -------
436,553 43,937
Less current maturities 58,254 19,282
-------- -------
Long-term debt $378,299 $24,655
======== =======
</TABLE>
Related Party Credit Lines: In December 1997, a $700,000 line of credit was
obtained from a related party, Northwest Management Corp. ("NMC"), a shareholder
of the Company. In January 1999, the line of credit was increased to $785,000.
The president of NMC, who is also a shareholder of the Company, has the power to
vote NMC shares, which are owned by his two children. The line was terminated by
mutual consent of both parties upon full repayment on June 21, 2000 of the
outstanding balance of $200,000. Interest was calculated at a rate of 12% per
annum.
In October 2000, a $500,000 line of credit was obtained from a related party,
NWM Capital, LLC. ("NWM"), which is owned by a shareholder of the Company. In
December 2000, the line of credit was increased to $658,000. The line, under
which there was an outstanding balance of $306,500 at November 30, 2000, expires
on October 31, 2002. Interest is calculated at a rate of 15% per annum. Monthly
interest only payments are due through October 31, 2002. Commencing on December
1, 2002, monthly payments will be $34,000 per month plus interest, with a final
payment of any outstanding balance at October 31, 2003, the maturity date. The
credit line may only be prepaid on six months prior written notice. The Company,
at the option of the lender, may be required to prepay up to an aggregate of 20%
of the stated principal amount of the credit line on 30 days prior written
notice. There were no commitment fees paid in connection with this line of
credit.
The line has a joint and several obligation of the Company and its subsidiary,
Medical Financial Corp. The line is collateralized by the second mortgage
receivable in Granby, Connecticut and certain purchased insurance claims
receivable of Medical Financial Corp., which are not older than six months (see
Note 4) equal to at least 222% of the principal sum outstanding under the line.
Related party escrow loan: In February 1999, a related partnership, whose
partners are directors, officers and shareholders of the Company, committed to
place in an escrow account until March 15, 2001 an investment portfolio, which
at the time was valued at
11
<PAGE> 13
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
6. NOTES PAYABLE (CONTINUED)
$240,000, for the benefit of the Medical Financial Corp. subsidiary. This
investment portfolio was held in escrow and used as collateral for the purpose
of obtaining margin loans. All risks and rewards of the investment portfolio
pass to the related party. The Company, being the primary obligor on the margin
loans, is responsible for the repayment of the loans. The margin loans bear
interest at a variable rate based on market condition set at the discretion of
the investment brokerage firm. A fee is payable monthly to the related party at
the rate of 5% per annum on the value of the investment escrow account. This fee
is included in interest expense. Proceeds from the loan may only be used to fund
the purchase of certain medical receivables. The loan is repaid as payment is
received from such receivables. On June 26, 2000, the then outstanding balance
of $170,000 was paid in full. On June 30, 2000, the line was terminated by
mutual consent of both parties.
Interest expense on these related party borrowings was $10,358 and $33,738 for
the nine months ended November 30, 2000 and 1999.
Capital Lease Obligations: The Company has acquired certain equipment under
various capital leases expiring in 2004. The leases provide for monthly payments
of principal and interest of $5,782 and have been capitalized at imputed
interest rates of 10.00% to 16.72%.
Aggregate maturities of the amount of notes payable and capital leases for the
years ending February 28 are as follows:
<TABLE>
<CAPTION>
NOTES CAPITAL LEASE
PAYABLE OBLIGATIONS TOTAL
------- ----------- -----
<S> <C> <C> <C>
2001 (three months) $ - $ 17,347 $ 17,347
2002 - 66,625 66,625
2003 306,500 51,624 358,124
2004 - 11,393 11,393
-------- -------- --------
306,500 146,989 453,489
Amount representing interest - 16,936 16,936
-------- -------- --------
Total (a) $306,500 $130,053 $436,553
======== ======== ========
</TABLE>
(a) -- Total capital lease obligations represent present value of minimum lease
payments.
7. MINIMUM OPERATING LEASE COMMITMENTS
Subject to annual real estate adjustments, the following is a schedule of future
minimum rental payments required under the Company's operating leases for the
years ending February 28:
12
<PAGE> 14
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
7. MINIMUM OPERATING LEASE COMMITMENTS (CONTINUED)
<TABLE>
<S> <C>
2001 (three months) $ 42,100
2002 139,600
2003 130,920
2004 133,556
2005 138,744
Thereafter 160,800
--------
Total $745,720
========
</TABLE>
8. INCOME TAXES
The provision for income taxes consist of the following:
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
NOVEMBER 30, NOVEMBER 30,
2000 1999 2000 1999
---- ---- ---- ----
<S> <C> <C> <C> <C>
Current:
Federal $ - $ - $ - $ -
State 4,928 4,925 15,130 15,223
------- ------- ------- -------
Total current 4,928 4,925 15,130 15,223
------- ------- ------- -------
Deferred:
Federal -- -- -- --
State -- -- -- --
------- ------- ------- -------
Total deferred -- -- -- --
------- ------- ------- -------
Total $ 4,928 $ 4,925 $15,130 $15,223
======= ======= ======= =======
</TABLE>
9. DISCONTINUED OPERATIONS
On May 14, 1999 the Company sold Wendclark, Inc., one of the two subsidiaries
that operated in the food service division. The Company received $975,000 in
cash, resulting in a gain of $96,303, which was recorded during the three months
ended May 31, 1999. As a result of this sale, $2,342,555 of debt that was
carried by Wendclark was assumed by the buyer. On May 23, 2000 the Company
committed to sell Wendcello Corp., the remaining subsidiary that operated in the
food service division. On June 20, 2000 the Company completed the sale of
Wendcello Corp., including all of its assets and liabilities, and received
$1,575,000 in cash, resulting in a gain of approximately $381,000 that was
recorded during the six months ended August 31, 2000. As a result of this sale,
$125,000 of current debt that was carried on Wendcello was eliminated. During
the period from May 23, 2000 (the measurement date for discontinuing operations
of the food service division) to June 20, 2000 (disposal date), net income from
operations of the discontinued food service division was $11,700. The results of
operations of both subsidiaries have been classified as discontinued operations
and prior periods have been restated.
13
<PAGE> 15
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
9. DISCONTINUED OPERATIONS (CONTINUED)
The net assets of the discontinued operations are as follows:
<TABLE>
<CAPTION>
NOVEMBER 30 FEBRUARY 29
2000 2000
---- ----
<S> <C> <C>
Cash & cash equivalents $ -- $ 328,607
Inventories -- 62,360
Other current assets -- 146,552
Property and equipment, at cost -- 2,352,846
Less accumulated depreciation and amortization -- (1,548,005)
Other assets -- 536,579
------- -----------
Total assets -- 1,878,939
------- -----------
Accounts payable and accrued expenses -- 554,397
Other current liabilities -- 149,650
------- -----------
Total liabilities -- 704,047
------- -----------
Net assets of discontinued operations $ -- $ 1,174,892
===== ===========
</TABLE>
A summary of the results of discontinued operations for the food services
division is as follows for the nine months and three months ended:
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
NOVEMBER 30 NOVEMBER 30
2000 1999 2000 1999
---- ---- ---- ----
<S> <C> <C> <C> <C>
Operating revenues, including
gain on sale of subsidiary of $-0-
for three months ended November 30,
2000 and 1999, $381,182 for the
nine months ended November 30, 2000
and $96,303 for the nine months
ended November 30, 1999 $ -- $ 2,702,854 $ 3,714,425 $ 9,596,003
Operating expenses -- 2,644,474 3,316,091 9,201,153
----------- ----------- ----------- -----------
Income from operations -- 58,380 398,334 394,850
Interest expense, net of
interest (income) -- (1,290) (1,774) 41,407
----------- ----------- ----------- -----------
Income before income taxes -- 59,670 400,108 353,443
Income taxes -- (1,250) 1,080 --
----------- ----------- ----------- -----------
Income from discontinued
operations, net of taxes $ -- $ 60,920 $ 399,028 $ 353,443
=========== =========== =========== ===========
</TABLE>
10. MINORITY INTEREST
Minority interest in subsidiary represents the remaining 20% ownership of the
Class A members of FRM NY Capital, LLC, the subsidiary that operates in the
Capco division.
14
<PAGE> 16
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
11. BUSINESS SEGMENT INFORMATION
Operating segments are managed separately and represent separate business units
that offer different products and serve different markets. The Company's
reportable segments include: (1) real estate, (2) medical (3) capco and (4)
other, which is comprised of corporate overhead and net assets of discontinued
operations. The real estate segment operates in New York and Connecticut. The
medical segment operates in New York and New Jersey. The capco segment was
formed on September 14, 2000 and operates only in New York.
Upon the certification of Capco by New York State on November 28, 2000, an
insurance company can purchase up to $10 million of debt of Capco and receive a
dollar-for-dollar tax credit spread out over a 10 year period beginning in 2002.
Such an investing insurance company is called a "Certified Investor" and Capco
will seek one or more such investors for $10 million. Capco Program Three
authorizes state tax credits of up to $150 million for all insurance company
participants. Capco will use (i) its own capital of $500,000, $395,000 of which
was supplied by the Company, $100,000 by Daniel Elstein who was a director of
FRMO Corp. in 1997-1998 and $5,000 from FRMO Corp., plus (ii) the investment of
the Certified Investor to take substantial equity interests in New York
companies in order to encourage and assist them in creating, developing and
expanding their business. Capco's emphasis will be on viable small business
enterprises which have had difficulty in attracting institutional venture
capital and which will expand employment opportunities in New York, thereby
promoting the growth of the State's economy. By virtue of the equity interests,
Capco obtains in the Qualified Businesses, or through contemporaneous
agreements, it is expected that it will be a significant factor in the direction
and control of the Qualified Businesses in which it invests its funds. Capco's
mission is to be an active participant with the management of its selected
companies, in order to grow the values of the qualified company, its own
investment therein and the interest of the Certified Investor at the same time
that the enterprise contributes to more jobs and growth in New York State. As of
November 30, 2000, Capco had not yet commenced operations.
The accounting policies of the segments are the same as those described in the
summary of significant accounting policies included in the Company's Form 10,
Amendment No. 2 for the six months ended August 31, 2000 and for the year ended
February 29, 2000. All inter-segment balances have been eliminated.
Inter-segment balances that have not been capitalized, bear interest at the rate
of 10% per annum and are included in net interest expense. Business segment
information for the nine months and three months ended November 30, 2000 and
1999 follows. Certain prior year information has been reclassified to conform
with the current year presentation.
15
<PAGE> 17
MFC DEVELOPMENT CORP. AND SUBSIDIARIES
(A SUBSIDIARY OF FRMO CORP.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
11. BUSINESS SEGMENT INFORMATION (CONTINUED)
<TABLE>
<CAPTION>
REAL
ESTATE MEDICAL CAPCO OTHER TOTAL
------ ------- ----- ----- -----
<S> <C> <C> <C> <C> <C>
THREE MONTHS ENDED NOVEMBER 30, 2000
Total revenue from external customers $ 46,241 $ 541,614 $ -- $ -- $ 587,855
Loss from operations (32,193) (30,259) -- (128,319) (190,771)
Interest income (expense), net 8,500 (9,038) 3,153 -- 2,615
Minority interest -- -- (612) -- (612)
(Loss) income from continuing operations
before provision for income taxes (23,693) (39,297) 2,541 (128,319) (188,768)
Capital expenditures 4,322 5,818 -- -- 10,140
Depreciation and amortization 929 20,310 -- 937 22,176
THREE MONTHS ENDED NOVEMBER 30, 1999
Total revenue from external customers $ 176,216 $ 197,932 $ -- $ -- $ 374,148
Income (loss) from operations 19,909 (172,978) -- (146,716) (299,785)
Interest income (expense), net 51,036 (52,286) -- -- (1,250)
Minority interest -- -- -- -- --
Income (loss) from continuing operations
before provision for income taxes 70,945 (225,264) -- (146,716) (301,035)
Capital expenditures 4,185 12,229 -- 1,248 17,662
Depreciation and amortization 2,450 13,324 -- -- 15,774
NINE MONTHS ENDED NOVEMBER 30, 2000
Total revenue from external customers $ 208,171 $ 1,404,943 $ -- $ -- $ 1,613,114
(Loss) from operations (99,690) (457,402) -- (334,221) (891,313)
Interest income (expense), net 30,782 (33,509) 3,153 -- 426
Minority interest -- -- (612) -- (612)
(Loss) income from continuing operations
before provision for income taxes (68,908) (490,911) 2,541 (334,221) (891,499)
Assets - continuing 4,032,767 5,004,045 503,072 17,553 9,557,437
Assets - discontinued -- -- -- -- --
Total assets 4,032,767 5,004,045 503,072 17,553 9,557,437
Capital expenditures 4,322 184,028 -- 500 188,850
Depreciation and amortization 2,143 60,121 -- 2,812 65,076
NINE MONTHS ENDED NOVEMBER 30, 1999
Total revenue from external customers $ 555,931 $ 807,513 $ -- $ -- $ 1,363,444
Income(loss) from operations 31,968 (219,247) -- (335,660) (522,939)
Interest income (expense), net 129,454 (160,022) -- -- (30,568)
Minority interest -- -- -- -- --
Income (loss) from continuing operations
before provision for income taxes 161,422 (379,269) -- (335,660) (553,507)
Assets - continuing 5,098,194 3,019,441 -- 21,262 8,138,897
Assets - discontinued -- -- -- 1,875,872 1,875,872
Total assets 5,098,194 3,019,441 -- 1,897,134 10,014,769
Capital expenditures 4,185 79,635 -- 1,248 85,068
Depreciation and amortization 5,671 38,358 -- -- 44,029
</TABLE>
16
<PAGE> 18
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND
FINANCIAL CONDITION
All statements contained herein that are not historical facts, including but not
limited to, statements regarding future operations, financial condition and
liquidity, expenditures to develop real estate owned by the Company, future
borrowing, capital requirements and the Company's future development plans are
based on current expectations. These statements are forward looking in nature
and involve a number of risks and uncertainties. Actual results may differ
materially. Among the factors that could cause actual results to differ
materially are the following: changes in the business of the Company's medical
provider clients, changes in the real estate and financial markets and other
risk factors described herein and in the Company's reports filed and to be filed
from time to time with the Commission. The discussion and analysis below is
based on the Company's unaudited consolidated financial statements for the nine
months and three months ended November 30, 2000 and 1999. The following should
be read in conjunction with the Management's Discussion and Analysis of results
of operations and financial condition included in Form 10, Amendment No. 2 for
the six months ended August 31, 2000 and for the year ended February 29, 2000.
OVERVIEW
MFC generates revenues from two business segments: real estate and medical. A
third segment, Capco, was formed during the three months ended November 30, 2000
and was not yet operational. The real estate segment consists of various parcels
of real estate, held for future development and sale, in which co-investors also
have interests, and mortgage notes receivable on two properties that were
previously sold. The medical segment consists of three Limited Liability
Companies which act as service organizations for providers of medical services
and a wholly-owned subsidiary, Medical Financial Corp., which purchases medical
insurance claims receivable, paying cash to the medical provider in return for a
negotiated fee. The Capco segment consists of an 80% ownership in FRM NY
Capital, LLC, a certified capital company as described in Note 3 and Note 11 of
the consolidated financial statements.
Revenues in the real estate division vary substantially from period to period
depending on when a particular transaction closes and depending on whether the
closed transaction is recognized for accounting purposes as a sale or reflected
as a financing or is deferred to a future period. On May 23, 2000 the Company
committed to sell Wendcello Corp., the remaining subsidiary that operated in the
food service division. On June 20, 2000 the Company completed the sale and
received $1,575,000 in cash, resulting in a gain of approximately $381,000 that
was recorded during the six months ended August 31, 2000. As a result of that
sale and the sale of the Wendclark subsidiary in May 1999, the food service
segment has been classified as discontinued operations and prior periods have
been restated. The consolidated financial statements and the discussion below
include the operations of the Company's parent, FRMO Corp., as if the transfer
of assets had occurred at the beginning of the periods presented.
17
<PAGE> 19
RESULTS OF OPERATIONS
2000 PERIOD COMPARED TO THE 1999 PERIOD
The Company's revenues from continuing operations increased by $214,000 or 57%,
for the three months ended November 30, 2000 ("2000") to $588,000 from $374,000
for the three months ended November 30, 1999 ("1999"). The Company's revenues
from continuing operations increased by $250,000 or 18%, for the nine months
ended November 30, 2000 ("2000") to $1,613,000 from $1,363,000 for the nine
months ended November 30, 1999 ("1999"). The increase in both the nine month and
three month periods was a result of an increase in the medical division, offset
by decreased revenues in the real estate division.
Revenue in the real estate division decreased in 2000 by $130,000, to $46,000
for the three month period and decreased by $348,000 to $208,000 for the nine
month period. The decrease in revenue in both the three month and nine month
periods were due to decreases of $85,000 and $227,000 in the sales of real
estate in the three month and nine month periods ended in 2000 as compared to
1999. Rental income decreased by $10,000 and $15,000 in the three months and
nine months ended in 2000 because rent is no longer being received on the
properties that were sold during the remainder of fiscal 2000. The $35,000 and
$106,000 decrease in the three months and nine months ended in 2000 in interest
from mortgages was attributable to a decrease in accrued interest income on the
mortgage receivable from the property located in Goshen, NY. Interest is no
longer being accrued on this mortgage because the annual interest payment that
was due in February 2000 has not been paid.
The $344,000 increase in revenues in the medical division for the three month
period ended in 2000 was due to an increase in both earned fees from the
purchase and collection of medical claims and management fees. The $597,000 net
increase in revenue in the medical division for the nine month period ended in
2000 was due to an increase in management fees, offset by a decrease of fees
from the purchase and collection of medical claims.
The increase in management fees of $240,000 and $660,000 for the three months
and nine months ended in 2000, was a result of the ownership, beginning in
February 2000, of an MRI facility that provides management services to a finance
client's radiology practice. Management fees were also generated, beginning in
April 2000, from the management of a finance client's physical therapy practice.
Two other finance client's practices were managed for a temporary period in
2000. These fees are net of reserves of $70,000 and $190,000 for the three
months and nine months ended November 30, 2000.
The increase in earned fees from the purchase and collection of medical claims
of $104,000 for the three month period was due to an increase in medical claims
purchased in current and earlier periods, which resulted in an increase in
revenue recognition over the period of collections, which is usually six months.
The increase in claims purchased was due to the Company obtaining new clients
and additional purchases from existing clients. The increase in purchases during
the three months ended in 2000 resulted in an overall increase in purchases of
$1,653,000 during the nine month period ended in 2000 as compared to the
18
<PAGE> 20
same nine month period ended in 1999. The income that is derived from these
purchases is deferred and recognized as the claims are collected during an
average six month period. The decrease in earned fees of $63,000 for the nine
month period was due to a decrease in medical claims purchased in earlier
periods, which resulted in a decrease in revenue recognition over the period of
collections, which is usually six months. The decrease in claims purchased in
earlier periods was due to the Company's decision to be more selective in the
bill purchasing process. Since the Company has become more selective in
determining which bills to purchase, the collection process is more efficient,
since the insurance companies are less likely to delay or question certain
procedures. This reduces the cost and time of the Company's collection effort
for each bill and results in a more rapid collection of the receivable.
Costs and expenses from continuing operations increased by $105,000, or 16%, for
the three months ended in 2000, to $779,000 as compared to $674,000 for the same
period ended in 1999. Costs and expenses from continuing operations increased by
$618,000, or 33%, for the nine months ended in 2000, to $2,504,000 as compared
to $1,886,000 for the same period ended in 1999. The net increase for the three
months ended in 2000 was due to increases of $194,000 in the medical division
and $6,000 in depreciation and amortization, which were offset by decreases of
$76,000 in the real estate division and $19,000 in corporate expenses. The net
increase for the nine months ended in 2000 was due to increases of $814,000 in
the medical division and $21,000 in depreciation and amortization, which were
offset by decreases of $213,000 in the real estate division and $4,000 in
corporate expenses.
The decrease in costs and expenses in the real estate division in both the three
month and nine month periods ended in 2000 were due to a decrease in the amount
of properties sold in 2000, which results in a decrease in the cost of sales.
Operating expenses also decreased in 2000, after a portion of the Hunter
property and all of the Brookfield property were sold during the last three
quarters of fiscal 2000.
The costs and expenses in the medical division for the three month and nine
month periods ended in 2000 was $552,000 and $1,802,000. The net increase of
$194,000 for the three month period was due to expenses of $228,000 that are
related to the three new subsidiaries that were formed in 2000 to manage the
operations of certain medical practices, offset by a decrease of $34,000 in
medical receivable expenses. The decrease in medical receivable expenses is
primarily due to a reduction of the amount of bad debt reserves for the three
month period ended in 2000.
The increase of $814,000 for the nine month period was due to expenses of
$739,000 that are related to the three new subsidiaries and a $75,000 increase
in medical receivable expenses. The $75,000 increase in medical receivable
expenses in the nine month period is attributable to additional expenses
incurred that were needed to properly service the current additions and
projected increases to the client base. These expenses included additional (i)
staff and related employment costs, in part due to reclassifying a portion of
executive salaries from corporate, part due to the hiring of additional
employees and part due to annual salary increases, (ii) occupancy and office
costs, (iii) arbitration costs in connection with the collection of claims
receivable and (iv) closing costs that are related to new clients. The
infrastructure of the company as established, can now service a greater number
of clients than currently exists. This is necessary to efficiently service
expected new clients with properly trained employees.
19
<PAGE> 21
The decrease in corporate expenses of $19,000 and $4,000 in the three month and
nine month periods ended in 2000 is primarily due to reductions and
reallocations of professional fees to the medical division. The increase in
depreciation and amortization of $6,000 and $21,000 in the three month and nine
month periods ended in 2000 is attributable to additional depreciation as a
result of increased capital expenditures in the medical financing division.
Interest expense for the three months ended 2000 was $6,000, unchanged from
1999. Interest expense for the nine months ended 2000 was $19,000, a decrease of
$19,000 from $38,000 in 1999. The decrease was attributable to the debt that was
eliminated in 1999 when a portion of the proceeds from the sale of the Wendclark
subsidiary was used to repay amounts that had been borrowed to finance the
purchase of medical claims receivable, offset by acquisition, by capital lease,
of an MRI machine in the medical division.
Income from discontinued operations for the three month period, which included
the operations of the Wendcello subsidiary in 1999, decreased by $61,000 to
nothing in 2000, due to the sale of that subsidiary in the quarter ended August
31, 2000. The increase for the nine month period was $46,000, to $399,000 in
2000. The increases in 2000 were primarily due to the gain of $381,000 from the
sale of the Wendcello subsidiary in the nine month period. The increase in nine
month period, which included the gain on sale of Wendcello were offset by the
profits from that subsidiary that were included in the entire 1999 period.
For the reasons noted above, the Company's net loss was reduced by $51,000 for
the three months ended in 2000 to $194,000 as compared to a net loss of $245,000
in 1999. The loss for the nine month period in 2000 was $508,000, $293,000
greater than the loss of $215,000 in 1999.
LIQUIDITY AND CAPITAL RESOURCES
The Company's two continuing business activities and discontinued operations
during the nine months ended November 30, 2000 resulted in a decrease of cash in
the amount of $1,000. The Company expects the continued growth of its medical
division to increase based on its on-going negotiations with prospective new
clients, which are expected to be obtained in the next few months. These
prospective clients will result in an increase in the amount of cash needed to
purchase their medical insurance claims receivable. The funds for those needs
are expected to be provided from the balance of the $658,000 credit line.
Additional funds may be provided for from financing activities such as
additional asset-based borrowing facilities on the Company's mortgages and
accounts receivable and the sale of real estate assets.
The real estate division is not expected to be a significant user of cash flow
from operations, due to the elimination of carrying costs on the real estate
that was sold during the year ended February 29, 2000 and the nine months ended
November 30, 2000. The Company's real estate assets in Hunter, NY are owned free
and clear of mortgages. Further development of this property, at any significant
cost, is expected to be funded by the sale of property in Hunter or asset-based
financing. The mortgage receivable on the Goshen, NY property does not call for
principal payments until February 28, 2002, however, interest payments in the
amount of $30,000 are due annually. The annual payment that was due on February
29, 2000 has not been paid, which resulted in the suspension of interest being
accrued.
20
<PAGE> 22
The Company believes that its present cash resources and the cash available from
financing activities will be sufficient on a short-term basis and over the next
12 months to fund continued expansion of its medical financing business, its
company-wide working capital needs and expected investments in property and
equipment. The Company intends to pace its growth in the medical financing
division to its capacity to provide the funds internally and from its financing
activities.
Cash used by operations during the nine months ended November 30, 2000 was
$466,000, as compared to $269,000 being used in the same period in 1999. The
$197,000 increase in the use of cash in 2000 was due to a net loss for the nine
months ended in 2000 of $508,000 (net of $381,000 gain on sale of subsidiary and
$208,000 provision for bad debts) as compared to a net loss of $215,000 (net of
$96,000 gain on sale of subsidiary and $22,000 provision for bad debts) in 1999,
a decrease in the sale of real estate, which resulted in a decrease in
collections of $212,000, offset by fluctuations in operating assets and
liabilities (including net assets of discontinued operations) primarily caused
by timing differences.
Cash provided by investing activities was $114,000 for the nine months ended in
2000 as compared with $1,372,000 being provided in 1999. The net decrease of
$1,258,000 was primarily due to the increase in medical insurance claims
receivable (net of amounts due to finance customers for payments of residual
collections) by $1,372,000 in 2000, compared to a $464,000 decrease in 1999. The
increase in 2000 was attributable to a greater amount of bills purchased,
beginning during the month of May from new clients. The use of cash by the
medical division was offset by an increase of $600,000 from discontinued
operations, resulting from the sale of the Wendcello subsidiary in June 2000.
Net cash provided by financing activities was $352,000 in 2000 as compared with
$854,000 being used in 1999. The $1,206,000 increase in 2000 was primarily due
to $275,000 of net borrowing in 2000 as compared to $854,000 of net debt
repayments in 1999. In addition, the company received $105,000 from a minority
interest in 2000. These proceeds were offset by the use of $28,000 to purchase
and acquire treasury stock in 2000.
EFFECTS OF NEW ACCOUNTING PRONOUNCEMENTS
ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
In June 1999, the Financial Accounting Standards Board issued Statement No. 137,
amending Statement No. 133, "Accounting for Derivative Instruments and Hedging
Activities", which extended the required date of adoption to the years beginning
after June 15, 2000. The Statement permits early adoption as of the beginning of
any fiscal quarter after its issuance. The Company expects to adopt the new
Statement effective March 1, 2001. The Company does not anticipate that the
adoption of this Statement will have any effect on its results of operations or
financial position.
REVENUE RECOGNITION IN FINANCIAL STATEMENTS
The Company expects to adopt Securities and Exchange Commission Staff Accounting
Bulletin 101 ("SAB 101"), Revenue Recognition in Financial Statements in the
quarter
21
<PAGE> 23
starting December 1, 2000. SAB 101 requires revenue to either be realized or
realizable and earned prior to recognition. This generally does not occur until
there is persuasive evidence of an arrangement, delivery has occurred or
services have been rendered, the price is fixed or determinable, and
collectibility is reasonably assured.The Company does not anticipate that the
adoption of SAB 101 will have any impact on the Company's current and prior
revenue recognition policies and its results of operations or financial
position.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company's market risk arises principally from the interest rate risk related
to its receivables. Interest rate risk is a consequence of having fixed interest
rate receivables in the Company's Real Estate and Medical Divisions. The Company
is exposed to interest rate risk arising from changes in the level of interest
rates.
PART II - OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
a) EXHIBITS.
None
b) REPORTS ON FORM 8k.
None
22
<PAGE> 24
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
MFC DEVELOPMENT CORP.
By: /S/ VICTOR BRODSKY
---------------------------
Victor Brodsky
Vice President and
Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: January 12, 2001
23
